Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study.
Borden BA, Galecki P, Wellmann R, Danahey K, Lee SM, Patrick-Miller L, Sorrentino MJ, Nanda R, Koyner JL, Polonsky TS, Stadler WM, Mulcahy C, Kavitt RT, Ratain MJ, Meltzer DO, O'Donnell PH.
Borden BA, et al. Among authors: wellmann r.
Pharmacogenet Genomics. 2019 Feb;29(2):31-38. doi: 10.1097/FPC.0000000000000362.
Pharmacogenet Genomics. 2019.
PMID: 30531377